# Study of Smith-Lemli-Opitz Syndrome

> **NCT00001721** · — · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 130 (actual)

## Conditions studied

- Smith-Lemli-Opitz Syndrome

## Interventions

- **DRUG:** Cholesterol Suspension
- **DRUG:** CRH
- **DRUG:** Cholesterol

## Key facts

- **NCT ID:** NCT00001721
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09-13
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001721, "Study of Smith-Lemli-Opitz Syndrome". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00001721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*